Leveraging its position as a global law firm, the erudite team at Herbert Smith Freehills LLP is noted for having excellent capabilities managing both contentious and non-contentious matters for a roster of clients which includes large multi-billion pharmaceutical and medical companies. Noted for handling parallel proceedings across many jurisdictions, the team is led by Alexandra Neri and Frédéric Chevallier, who has gained a wealth of experience in life sciences and technology patent litigation, including the related regulatory aspects of pharmaceuticals. Recent work to highlight includes representing a major French multinational pharmaceutical and healthcare company in complex patent infringement litigation before the UPC.
Legal 500 redaktioneller Kommentar

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘Creativity - business oriented - flexibility - speed.'
  • 'Frédéric Chevallier is recommended.'

Kernmandanten

  • Sanofi
  • Roche
  • Foundation Medicine
  • Millennium Pharmaceuticals, Inc.
  • Janssen Pharmaceuticals

Highlight-Mandate

  • Advising Sanofi on one of its innovative products, Jevtana, for the treatment of prostate cancer (cabazitaxel) in four infringement actions started before the Unified Patent Court.
  • Advising Sanofi on one of its fastest growing products, Jevtan®, for the treatment of prostate cancer (cabazitaxel).
  • Representing Millennium Pharmaceuticals Inc., Takeda Pharmaceuticals and its exclusive licensee Janssen, in the enforcement strategy of their patents protecting their blockbuster bortezomib comprising product against generic entry.

Anwält*innen

Praxisleitung

Alexandra Neri; Frédéric Chevallier